cytostatica

( Patho)physiological function of the Multidrug Resistance protein MRP1 / Jan Willem Renesschema:ProductModel (Patho)physiological function of the Multidrug Resistance protein MRP1 / Jan Willem Renesschema:ProductModel 101 vragen over cytostaticaschema:ProductModel 101 vragen over cytostatica / [eindred.: G.J. ter Braak]schema:ProductModel 5-Aza-2'-deoxycytidine: preclinical and clinical studies : proceedings of the Workshop on 5-Aza-2'-deoxycytidine, Amsterdam, March 11, 1989 / ed. by Richard L. Momparler and Dick de Vosschema:ProductModel 5-Azacytidine : evaluation of the carcinogenicity and genotoxicity / Subcommittee on the classification of carcinogenic substances of the Dutch Expert Committee on Occupational Standards, a committee of the Health Council of the Netherlandsschema:ProductModel 5-fluorodeoxyuridine-dipalmitate, a lipophilic prodrug in immunoliposomes / Gerrit Arjan Koningschema:ProductModel 5-fluorodeoxyuridine-dipalmitate, a lipophilic prodrug in immunoliposomes / Gerrit Arjan Koningschema:ProductModel 5-Fluorouracil and intestinal healing : an experimental study / Jan Willem Daniël de Waardschema:ProductModel Anthracycline resistance in childhood leukemia / Monique Louise den Boerschema:ProductModel Beroepsrisico door cyclofosfamide bij verpleegkundigen : een pilotonderzoek / H.L.Y. van Hoorn-Vosschema:ProductModel Bijwerking van cytostatische behandeling : pathofysiologie, preventie, therapie / ed.: J. de Koning, J. Grijzen, J.H.A. Heltzel ; [inl. J.Th.M. Burghouts ; bijdragen J.D.R. Peereboom-Wynia ... et al.]schema:ProductModel Bioanalysis and clinical pharmacology of camptothecin topoisomerase I inhibitors / Virginie Mechelina Maria Herbenschema:ProductModel Bioanalysis and clinical pharmacology of paclitaxel / Manon Thirza Huizingschema:ProductModel Biochemical and pharmacological approach to the clinical development of the new anticancer agent Brequinar Sodium (NSC 368390) / Gilberto Schwartsmannschema:ProductModel Brain neurosecretory cytokines : immune response and neuronal survival / Armen A. Galoyanschema:ProductModel Cellular pharmacokinetics and pharmacodynamics of anthracyclines in man / Paulus Arnold Johan Spethschema:ProductModel Cellular resistance to adriamycin and cisplatin : the role of detoxifying systems / Jacoba Meyerschema:ProductModel Chlorozotocin : evaluation of the carcinogenicity and genotoxicity / Subcommittee on the classification of carcinogenic substances of the Dutch Expert Committee on Occupational Standards, a committee of the Health Council of the Netherlandsschema:ProductModel Cis-Diamminedichloroplatinum (II) (Cisplatin) : clinical pharmacologic studies / Jan Baptist Vermorkenschema:ProductModel ... show all 115

chemotherapieskos:Concept